Thymoquinone reduces cardiac damage caused by hypercholesterolemia in apolipoprotein E-deficient mice

BACKGROUND: Hypercholesterolemia is a well-established risk factor for cardiac damage, which can lead to cardiovascular diseases. Many studies have shown that thymoquinone protected rats from doxorubicin-induced cardiotoxicity and cardiac damage. The aim of this study was to investigate the possible...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jingyi, Zhu, Liyue, Liu, Hongyang, Li, Mengye, Liu, Yingshu, Yang, Fan, Pei, Zuowei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062953/
https://www.ncbi.nlm.nih.gov/pubmed/30049280
http://dx.doi.org/10.1186/s12944-018-0829-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062953/
https://www.ncbi.nlm.nih.gov/pubmed/30049280
http://dx.doi.org/10.1186/s12944-018-0829-y

Ejemplares similares